IL17A and colitis: Since it was found to be capable of suppressing increased IL-17, and enhancing decreased IL-4 expressions, a characteristic of dextran sulfate sodium (DSS)- induced colitis, and presented a partial protection against DSS-induced colitis in mice [52].